SMMT
Summit Therapeutics Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.
Market Cap: 3.4 Billion
Primary Exchange: NASDAQ
Website: summitplc.com
Shares Outstanding: 702 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 2.243062418572863
Sector:
Industry:
Ethical Flags
Longest drawdown: 1302 trading days
From: 2017-09-11 To: 2024-03-07
Lowest Point:
Summit Therapeutics reports Q1 results
via: SeekingAlpha at 2019-06-12 03:03:19:000
Summit Therapeutics (NASDAQ: SMMT ): Q1 GAAP EPS of -$0.04. More news on: Summit Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more … read more...
Summit Therapeutics reports Q1 results
via: SeekingAlpha at 2019-06-12 03:03:19:000
Summit Therapeutics (NASDAQ: SMMT ): Q1 GAAP EPS of -$0.04. More news on: Summit Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more … read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|